UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 240

Sortiert nach

Cannabinoid CB₂ receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice

Proceedings of the National Academy of Sciences - PNAS, 2014-11, Vol.111 (46), p.E5007-E5015

2014

Link zum Volltext

Verfügbarkeit prüfen

Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice

Nature neuroscience, 2011-07, Vol.14 (9), p.1160-1166

2011

Link zum Volltext

Verfügbarkeit prüfen

Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference

Scientific reports, 2017-12, Vol.7 (1), p.17410-17, Article 17410

2017

Link zum Volltext

Verfügbarkeit prüfen

Different receptor mechanisms underlying phytocannabinoid‐ versus synthetic cannabinoid‐induced tetrad effects: Opposite roles of CB1/CB2 versus GPR55 receptors

British journal of pharmacology, 2020-04, Vol.177 (8), p.1865-1880

2020

Link zum Volltext

Verfügbarkeit prüfen

Examining the role of dopamine D2 and D3 receptors in Pavlovian conditioned approach behaviors

Behavioural brain research, 2016-05, Vol.305, p.87-99

2016

Link zum Volltext

Verfügbarkeit prüfen

CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ9-Tetrahydrocannabinol (Δ9-THC)-Induced Aversive Effects in Mice

Scientific reports, 2017-09, Vol.7 (1), p.1-15, Article 12315

2017

Link zum Volltext

Verfügbarkeit prüfen

Involvement of the ghrelin system in the maintenance of oxycodone self-administration: converging evidence from endocrine, pharmacologic and transgenic approaches

Molecular psychiatry, 2022-04, Vol.27 (4), p.2171-2181

2022

Link zum Volltext

Verfügbarkeit prüfen

Cocaine and cocaine expectancy increase growth hormone, ghrelin, GLP-1, IGF-1, adiponectin, and corticosterone while decreasing leptin, insulin, GIP, and prolactin

Pharmacology, biochemistry and behavior, 2019-01, Vol.176, p.53-56

2019

Link zum Volltext

Verfügbarkeit prüfen

Increased vulnerability to cocaine in mice lacking dopamine D₃ receptors

Proceedings of the National Academy of Sciences - PNAS, 2012-10, Vol.109 (43), p.17675-17680

2012

Link zum Volltext

Verfügbarkeit prüfen

β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly via CB2 and Non-CB2 Receptor Mechanisms

Frontiers in pharmacology, 2021-09, Vol.12, p.722476-722476

2021

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic potential of PIMSR, a novel CB1 receptor neutral antagonist, for cocaine use disorder: evidence from preclinical research

Translational psychiatry, 2022-07, Vol.12 (1), p.286-286, Article 286

2022

Link zum Volltext

Verfügbarkeit prüfen

Blockade of D3 receptors by YQA14 inhibits cocaine's rewarding effects and relapse to drug-seeking behavior in rats

Neuropharmacology, 2014-02, Vol.77, p.398-405

2014

Link zum Volltext

Verfügbarkeit prüfen

Critical assessment of how to study addiction and its treatment: human and non-human animal models

Pharmacology & therapeutics (Oxford), 2005-10, Vol.108 (1), p.18-58

2005

Link zum Volltext

Verfügbarkeit prüfen

Addiction and Brain Reward and Antireward Pathways

Advances in psychosomatic medicine, 2011, Vol.30, p.22-60

2011

Link zum Volltext

Verfügbarkeit prüfen

Metabotropic Glutamate Receptor 7 Modulates the Rewarding Effects of Cocaine in Rats: Involvement of a Ventral Pallidal GABAergic Mechanism

Neuropsychopharmacology (New York, N.Y.), 2009-06, Vol.34 (7), p.1783-1796

2009

Link zum Volltext

Verfügbarkeit prüfen

Dopamine D₃ receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats

European journal of pharmacology, 2011-06, Vol.659 (2-3), p.187-192

2011

Link zum Volltext

Verfügbarkeit prüfen

Chiral Resolution of the Enantiomers of the Slow-Onset Dopamine Reuptake Inhibitor CTDP-32476 and Their Activities

ACS omega, 2023-10, Vol.8 (39), p.35738-35745

2023

Link zum Volltext

Verfügbarkeit prüfen

PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats

Journal of psychopharmacology (Oxford), 2011-02, Vol.25 (2), p.263-273

2011

Link zum Volltext

Verfügbarkeit prüfen

Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats

The European journal of neuroscience, 2005-06, Vol.21 (12), p.3427-3438

2005

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of NAALADase by 2-PMPA attenuates cocaine-induced relapse in rats: a NAAG-mGluR2/3-mediated mechanism

Journal of neurochemistry, 2010-01, Vol.112 (2), p.564-576

2010

Link zum Volltext

Verfügbarkeit prüfen

Endocannabinoid signaling system and brain reward: Emphasis on dopamine

Pharmacology, biochemistry and behavior, 2005-06, Vol.81 (2), p.263-284

Gardner, Eliot L.

2005

Link zum Volltext

Verfügbarkeit prüfen

The selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in rats

Psychopharmacologia, 2008-03, Vol.196 (4), p.533-542

2008

Link zum Volltext

Verfügbarkeit prüfen

Cannabinoid CB 1 and CB 2 receptor mechanisms underlie cannabis reward and aversion in rats

British journal of pharmacology, 2019-05, Vol.176 (9), p.1268-1281

2019

Link zum Volltext

Verfügbarkeit prüfen

Cannabinoid CB1 and CB2 receptor mechanisms underlie cannabis reward and aversion in rats

British journal of pharmacology, 2019-05, Vol.176 (9), p.1268-1281

2019

Link zum Volltext

Verfügbarkeit prüfen

Addictive potential of cannabinoids: the underlying neurobiology

Chemistry and Physics of Lipids, 2002-12, Vol.121 (1), p.267-290

Gardner, Eliot L.

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 240

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(231)
Mit Volltextzugriff
(236)

Publikationsform

Artikel
(237)
Buchkapitel
(3)

Sprache

Englisch
(240)
Japanisch
(34)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cannabinoid CB₂ receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice

Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice

Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference

Different receptor mechanisms underlying phytocannabinoid‐ versus synthetic cannabinoid‐induced tetrad effects: Opposite roles of CB1/CB2 versus GPR55 receptors

Examining the role of dopamine D2 and D3 receptors in Pavlovian conditioned approach behaviors

CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ9-Tetrahydrocannabinol (Δ9-THC)-Induced Aversive Effects in Mice

Involvement of the ghrelin system in the maintenance of oxycodone self-administration: converging evidence from endocrine, pharmacologic and transgenic approaches

Cocaine and cocaine expectancy increase growth hormone, ghrelin, GLP-1, IGF-1, adiponectin, and corticosterone while decreasing leptin, insulin, GIP, and prolactin

Increased vulnerability to cocaine in mice lacking dopamine D₃ receptors

β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly via CB2 and Non-CB2 Receptor Mechanisms

Therapeutic potential of PIMSR, a novel CB1 receptor neutral antagonist, for cocaine use disorder: evidence from preclinical research

Blockade of D3 receptors by YQA14 inhibits cocaine's rewarding effects and relapse to drug-seeking behavior in rats

Critical assessment of how to study addiction and its treatment: human and non-human animal models

Addiction and Brain Reward and Antireward Pathways

Metabotropic Glutamate Receptor 7 Modulates the Rewarding Effects of Cocaine in Rats: Involvement of a Ventral Pallidal GABAergic Mechanism

Dopamine D₃ receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats

Chiral Resolution of the Enantiomers of the Slow-Onset Dopamine Reuptake Inhibitor CTDP-32476 and Their Activities

PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats

Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats

Inhibition of NAALADase by 2-PMPA attenuates cocaine-induced relapse in rats: a NAAG-mGluR2/3-mediated mechanism

Endocannabinoid signaling system and brain reward: Emphasis on dopamine

The selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in rats

Cannabinoid CB 1 and CB 2 receptor mechanisms underlie cannabis reward and aversion in rats

Cannabinoid CB1 and CB2 receptor mechanisms underlie cannabis reward and aversion in rats

Addictive potential of cannabinoids: the underlying neurobiology

Suchergebnisse filtern